Mayo Clinic today announced a strategic collaboration in biomanufacturing to deliver novel biotherapeutics for rare and complex conditions. The collaboration brings together science, engineering and manufacturing to advance Mayo Clinic's vision of bringing new cures to clinical care. The focus will be on therapies derived from human sources known as biologics -- cells, blood, enzymes, tissues, genes or genetically engineered cells -- for use in medicines. Therapeutics based on biologics have the potential to target exact tissues needing repair.
Pr Press Articles, Journals and News
Latest News
Mayo Clinic research shows bebtelovimab to be a reliable option for treating COVID-19 in era of BA.2, other subvariants
Mayo Clinic researchers say the monoclonal antibody bebtelovimab, already authorized by the Food and Drug Administration for emergency use on the omicron variant of COVID-19, is a reliable option to treat BA.2 and other COVID-19 subvariants. The findings of their multisite, retrospective study involving 3,607 high-risk patients appear in the Journal of Infectious Diseases.
Drs. Julie Louise Gerberding, Martine Rothblatt to join Mayo Clinic Board of Trustees
Julie Louise Gerberding, M.D., former director of the Centers for Disease Control and Prevention (CDC), and Martine Rothblatt, Ph.D., chairperson and CEO of United Therapeutics Corp. (Nasdaq:UTHR), were elected by the Mayo Clinic Board of Trustees as public trustees at its quarterly meeting on Aug. 12. They will join the Board of Trustees effective Nov. 10.
President Johnson meets with university’s military-connected students
Ohio State University President Kristina M. Johnson offered support and gratitude to members of the university military service community during a tour of Converse Hall last week. She also got to extend her appreciation to a quick-thinkingMarine.
左心室衰竭 -- 致命的无症状疾病
左心室功能障碍是心脏泵血功能低下的医学名称。在年龄超过60岁的族群中，大约有9%的人受这种疾病的影响。罗切斯特妙佑医疗国际(Mayo Clinic)的心脏病学专家Paul Friedman医学博士对这种疾病作出了解释，并介绍了相关的诊断和治疗方法。
فشل البطين الأيسر- الحالة المرضية الصامتة والتي قد تكون قاتلة
خلل البطين الأيسر هو الاسم الطبي لضخ القلب الضعيف، وهي حالة تؤثر على حوالي 9% من الأشخاص فوق سن الستين. بول فريدمان، دكتور الطب، طبيب القلب في مايو كلينك في مدينة روتشستر، يشرح هذه الحالة وكيف يمكن تشخيصها وعلاجها.
Mayo Clinic facilities recognized for environmental sustainability
ROCHESTER, Minn. -- Mayo Clinic locations in Arizona, Florida and Rochester, and Mayo Clinic Health System locations in Eau Claire and La Crosse, Wisconsin, have been recognized for their sustainability initiatives by Practice Greenhealth. This national organization recognizes health care organizations committed to continuous improvement in sustainability practices and programs.
Insuficiencia ventricular esquerda, a condicao silenciosa que pode ser fatal
Insuficiencia ventricular esquerda e o nome medico para um bombeamento cardiaco fraco. E uma condicao que impacta cerca de 9 por cento das pessoas acima de 60 anos. Dr. Paul Friedman, cardiologista da Mayo Clinic em Rochester, explica a condicao e como ela pode ser diagnosticada e tratada.
Insuficiencia ventricular izquierda: afeccion silenciosa que puede ser mortal
Disfuncion ventricular izquierda es el termino medico para corazon debilitado y consiste en una afeccion que afecta aproximadamente al 9 por ciento de personas mayores de 60 anos. El Dr. Paul Friedman, cardiologo de Mayo Clinic en Rochester, explica la afeccion y como diagnosticarla y tratarla.
